Manitowoc, WI, United States of America

Thomas W McMullin

USPTO Granted Patents = 13 

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 293(Granted Patents)


Location History:

  • Maintowoc, WI (US) (2002)
  • Manitowoc, WI (US) (2001 - 2015)

Company Filing History:


Years Active: 2001-2015

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Thomas W McMullin: Pioneering Innovations in Isoprenoid Production

Introduction:

Thomas W McMullin, a prolific inventor hailing from Manitowoc, WI, has left an indelible mark in the field of biotechnology with his groundbreaking work on isoprenoid production. With a total of 13 patents to his name, McMullin's contributions have revolutionized the biological methods of producing isoprenoids.

Latest Patents:

One of McMullin's recent patents involves the development of a recombinant yeast that enhances the production of isoprenoid compounds. By optimizing the carbon flow through the mevalonate pathway, this innovation ensures a more efficient synthesis process compared to traditional methods.

Career Highlights:

McMullin has been associated with esteemed companies like Arkion Life Sciences, LLC and Bio-technical Resources. His tenure with these organizations has provided him with the platform to research and implement cutting-edge technologies in the field of biotechnology, particularly in isoprenoid production.

Collaborations:

Throughout his career, McMullin has collaborated with distinguished professionals such as James R Millis and Julie Maurina-Brunker. Together, they have worked on various projects aimed at pushing the boundaries of innovation in biotechnology and enhancing the capabilities of isoprenoid production methods.

Conclusion:

In conclusion, Thomas W McMullin's inventive spirit and dedication to advancing biotechnological processes have solidified his reputation as a trailblazer in the field. His patents and collaborations stand as a testament to his drive for innovation and his significant contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…